Close

MSH3

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. MSH3 (mutS homolog 3) forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. Defects in MSH3 gene are a cause of susceptibility to endometrial cancer.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YC0030 Anti-MSH3 (1F6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Mouse 1F6 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0031 Anti-MSH3 (2F11) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Mouse 2F11 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0032 Anti-MSH3 (5A5) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Mouse 5A5 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0033 Anti-MSH3 (8E6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Mouse 8E6 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0930 Anti-MSH3 (1F6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Mouse 1F6 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0931 Anti-MSH3 (2F11) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Mouse 2F11 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0932 Anti-MSH3 (5A5) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Mouse 5A5 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0933 Anti-MSH3 (8E6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Mouse 8E6 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.